Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

المؤلفون: Zhang, Yunlin^1,2 (AUTHOR); Patel, Ruchi P.^1,2 (AUTHOR); Kim, Ki Hyun³ (AUTHOR); Cho, Hyungwoo⁴ (AUTHOR); Jo, Jae-Cheol⁵ (AUTHOR); Jeong, Seong Hyun⁶ (AUTHOR); Oh, Sung Yong⁷ (AUTHOR); Choi, Yoon Seok⁶ (AUTHOR); Kim, Sung Hyun⁷ (AUTHOR); Lee, Ji Hyun⁷ (AUTHOR); Angelos, Mathew^1,2 (AUTHOR); Guruprasad, Puneeth^1,2 (AUTHOR); Cohen, Ivan^1,2 (AUTHOR); Ugwuanyi, Ositadimma^1,2 (AUTHOR); Lee, Yong Gu^1,2,8 (AUTHOR); Pajarillo, Raymone^1,2 (AUTHOR); Cho, Jong Hyun⁹ (AUTHOR); Carturan, Alberto^1,2 (AUTHOR); Paruzzo, Luca^1,2 (AUTHOR); Ghilardi, Guido^1,2 (AUTHOR)
المصدر:
Molecular Cancer. 12/9/2023, Vol. 22 Issue 1, p1-23. 23p.